Cargando…
Fulminant toxoplasmic retino-choroiditis following intravitreal triamcinolone administration
We report two cases of fulminant toxoplasmic retinochoroiditis following intravitreal triamcinolone acetonide (IVTA) administration. Case 1: A 42-year-old female received IVTA for presumed non-infectious panuveitis. Within 2 months, she developed diffuse macular retinochoroiditis with optic disc ede...
Autores principales: | Rush, Ryan, Sheth, Saumil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339077/ https://www.ncbi.nlm.nih.gov/pubmed/22446913 http://dx.doi.org/10.4103/0301-4738.94059 |
Ejemplares similares
-
Efficacy of reduced dose of intravitreal triamcinolone acetonide in a case of active serpiginous choroiditis
por: Ghose, Avirupa, et al.
Publicado: (2016) -
Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia
por: Rishi, Pukhraj, et al.
Publicado: (2011) -
Management of macular epiretinal membrane by vitrectomy and intravitreal triamcinolone
por: Shukla, Dhananjay
Publicado: (2014) -
Management of recurrent inflammatory choroidal neovascular membrane secondary to Vogt-Koyanagi-Harada syndrome, using combined intravitreal injection of bevacizumab and triamcinolone acetate
por: Pai, Sivakami A, et al.
Publicado: (2012) -
Serum levels of neurotrophic factors in active toxoplasmic retinochoroiditis
por: Cordeiro, Cynthia Azeredo, et al.
Publicado: (2016)